SCHEMBL8103500

SCHEMBL8103500

CC(C)c1ncnn1Cc1ccc(-c2cccc(C(=O)O)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.46
PDE7A Q13946 1/20 0.45
PDE7B Q9NP56 1/20 0.45
KMO O15229 1/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
BCL2 P10415 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
DHFR P00374 1/20 0.43
LIFR P42702 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
ALOX5AP P20292 1/20 0.42
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8105152 0.86 HDAC1 (0.43) HDAC1HDAC6NPC1RAB9ASMN1; SMN2
SCHEMBL20569205 0.76 HDAC1 (0.45) HDAC1HDAC6NPC1RAB9ASMN1; SMN2
SCHEMBL8104958 0.74 PPARG (0.48) PPARGPDE7APDE7BKMOHDAC6
SCHEMBL10243325 0.73 BCL2 (0.71) KMORXRARXRBBCL2DHFR
SCHEMBL13756311 0.73 BCL2 (0.71) KMORXRARXRBBCL2DHFR
SCHEMBL8096036 0.73 AGTR1 (0.48) PPARGPDE7APDE7BKMOHDAC6
SCHEMBL8109215 0.72 RXRA (0.46) PPARGPDE7APDE7BKMOHDAC6
SCHEMBL8111149 0.71 PPARG (0.49) PPARGPDE7APDE7BKMOHDAC6
SCHEMBL8105171 0.70 PPARG (0.48) PPARGRXRARXRBNPC1RAB9A
SCHEMBL2627836 0.70 RXRA (0.71) KMORXRARXRBRXRGBCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed